Search Within

Sean McCarthy Devlin

Formats
  1. Meeting Abstract (374)
  2. Journal Article (215)
  3. Research Letter (15)
  4. Correspondence (5)
  5. Editorial (1)
  6. Review (1)
Groups
  1. Biostatistics Service (611)
  2. Epidemiology and Biostatistics (611)
  3. Department of Medicine (583)
  4. Hematologic Malignancies, Division of (582)
  5. Center for Hematologic Malignancies (579)
  6. Bone Marrow Transplant (465)

More Groups

People
  1. Sergio Giralt (377)
  2. Miguel-Angel Perales (300)
  3. Gunjan Shah (183)
  4. Molly Maloy (162)
  5. Parastoo Dahi (158)
  6. Michael Scordo (148)

More People

Years
  1. 2025 (14)
  2. 2024 (34)
  3. 2023 (52)
  4. 2022 (42)
  5. 2021 (36)
  6. 2020 (56)

More Years

Publications
  1. Blood (203)
  2. Biology of Blood and Marrow Transplantation (133)
  3. Bone Marrow Transplantation (51)
  4. Blood Advances (28)
  5. Transplantation and Cellular Therapy (25)
  6. Journal of Clinical Oncology (15)

More Publications

Publishers
  1. American Society of Hematology (231)
  2. Elsevier Inc. (175)
  3. Nature Publishing Group (73)
  4. Taylor & Francis Group (16)
  5. American Society of Clinical Oncology (15)
  6. Ferrata Storti Foundation (12)

More Publishers

Results (611)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Influence of obesity on the efficacy and toxicity of patients undergoing autologous hematopoietic cell transplantation for lymphoma
    Journal Article

    Lin, A.; Pearl, N.; Flynn, J.; Devlin, S.; Dahi, P.; Perales, M. A.; Scordo, M.; Shah, G. L.
    Clinical Lymphoma, Myeloma and Leukemia (2025)

    Fulltext@MSK | Save
  • Measuring the impact of new risk factors within survival models
    Journal Article

    Heller, G.; Devlin, S. M.
    Journal of the Royal Statistical Society Series C - Applied Statistics (2025)

    Fulltext@MSK | Save
  • Minimal residual disease as an early endpoint for accelerated drug approval in myeloma: A roadmap
    Review

    Landgren, O.; Devlin, S. M.
    Blood Cancer Discovery (2025)

    Fulltext@MSK | Save
  • Cancer cachexia and weight loss before CAR T-cell therapy for lymphoma are independently associated with poor outcomes
    Journal Article

    Valtis, Y. K.; Devlin, S.; Shouval, R.; Rejeski, K.; Corona, M.; De Abia, A. L.; Rivas-Delgado, A.; Luttwak, E.; Cassanello, G.; Landego, I.; more...
    Blood Advances (2025)

    Fulltext@MSK | Save
  • Prospective feasibility trial of pharmacokinetic directed melphalan for lymphoma patients undergoing autologous hematopoietic cell transplantation
    Meeting Abstract

    Hughes, C. F. M.; Lin, A.; Bromberg, M.; Devlin, S. M.; Saldia, A.; Engstler, D. E.; Hanley, D. M.; Aremu, Y.; Donach, M.; Hoover, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • CAR T-cell therapy for DLBCL with CNS involvement: Overall safe and effective with limited efficacy in patients with leptomeningeal disease
    Meeting Abstract

    Luttwak, E.; Cassanello, G.; Brown, S.; Devlin, S. M.; Imber, B. S.; Ip, A.; Leslie, L. A.; Accav, N. G.; Beyar-Katz, O.; Corona, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • NGS MRD negativity on day 28 after brexu cel in adults with R/R ALL is associated with favorable progression free survival
    Meeting Abstract

    Valtis, Y. K.; Nemirovsky, D.; Devlin, S. M.; Roloff, G. W.; Aldoss, I.; Jeyakumar, N.; Miller, K.; Zhang, A.; Sutherland, K. C.; Advani, A. S.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Comparative real-world outcomes of commercial CD19-directed CAR T-cell therapies in large B-cell lymphoma
    Meeting Abstract

    Deschè‚nes-Simard, X.; Bromberg, M.; Devlin, S. M.; Katz, O. B.; Ip, A.; Marcus, R.; Avigdor, A.; Ballweg, A.; Rabinovich, E.; Alhomoud, M.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • When can we define cure after CAR-T therapy in LBCL? insights from serial landmark analyses
    Meeting Abstract

    Gomez-Llobell, M.; Shouval, R.; Brown, S.; Accav, N. G.; Devlin, S. M.; Corona, M.; Rejeski, K.; Rivas-Delgado, A.; Luna, A.; Luttwak, E.; more...
    Blood (2024)

    Fulltext@MSK | Save
  • Impact of absolute lymphocyte count at pre-apheresis and pre-lymphodepletion on chimeric antigen receptor (CAR)-T therapy outcomes in relapsed refractory multiple myeloma (RRMM)
    Meeting Abstract

    Nishimura, N.; Mailankody, S.; Brown, S.; Devlin, S. M.; Costa, B. A.; Farzana, T.; Jurgens, E. M.; Firestone, R. S.; Nath, K.; Chung, D. J.; more...
    Blood (2024)

    Fulltext@MSK | Save